Assessing brain free fraction in early drug discovery

Expert Opinion on Drug Metabolism & Toxicology
Kevin Read, Simone Braggio

Abstract

The incorporation of brain tissue binding routinely in CNS drug discovery screening strategies has markedly changed the way CNS drug discovery is performed and is proving to be a valuable tool in identifying new therapies for CNS diseases. For many years emphasis has been placed on the magnitude of the brain to blood ratio, the bigger the better, even though, in many cases, brain total concentration (C(brain)) has no or, at best, poor correlation with receptor occupancy/pharmacodynamic readout. Today, C(brain) values measured during in vivo experiments are corrected for the fraction unbound measured through in vitro experiments using brain tissue homogenate or brain tissue slice to obtain an estimate of the brain unbound concentration (C(u,brain)), and this has been demonstrated across a range of CNS targets to give a much better correlation with receptor occupancy/pharmacodynamic readout. This apparently simple change in CNS lead optimisation strategy has de facto revolutionised the vision of the brain penetration concepts. This review will provide an overview of the use and applications of assessing brain free fraction to determine C(u,brain). Assessing brain free fraction to determine C(u,brain) in CNS lead optimisation stra...Continue Reading

References

Jan 1, 1988·Fundamental & Clinical Pharmacology·J P TillementJ Barre
May 2, 2000·Psychopharmacology·P B FitzgeraldR B Zipursky
Nov 5, 2002·Biopharmaceutics & Drug Disposition·J Cory Kalvass, Tristan S Maurer
Sep 6, 2003·Methods in Molecular Medicine·Andreas ReichelN Joan Abbott
Mar 9, 2004·Drug Discovery Today·William M Pardridge
Sep 24, 2004·Advanced Drug Delivery Reviews·Danny D ShenKimberly K Adkison
Oct 27, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Angela DoranChenghong Zhang
Oct 27, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tristan S MaurerDennis O Scott
Feb 14, 2006·Current Drug Metabolism·Andreas Reichel
Feb 28, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stacey Becker, Xingrong Liu
Jun 9, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingrong LiuJeffrey Van Deusen
Apr 5, 2007·The Journal of Pharmacology and Experimental Therapeutics·Scott G SummerfieldPhil Jeffrey
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P Jeffrey, S G Summerfield
Dec 7, 2007·Pharmaceutical Research·Margareta Hammarlund-UdenaesAnubha Gupta
Jan 29, 2008·Current Drug Metabolism·Jiunn H Lin
Nov 4, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S G SummerfieldA D Ruffo
Jan 1, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingrong LiuMario Monshouwer
Jan 23, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jeanette WatsonKevin D Read
Feb 10, 2009·Current Topics in Medicinal Chemistry·Margareta Hammarlund-UdenaesMarkus Fridén
Mar 21, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Markus FridénMargareta Hammarlund-Udenaes
Jun 1, 2008·Expert Opinion on Drug Discovery·Li DiGuy T Carter

❮ Previous
Next ❯

Citations

Sep 13, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Manolo MugnainiMassimo Bani
May 10, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Laura PiccoliMauro Corsi
Dec 30, 2011·Brain Structure & Function·Sylvia Van DorpeBart De Spiegeleer
Feb 13, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Elizabeth C M de Lange
Jun 4, 2011·Expert Opinion on Drug Metabolism & Toxicology·Mario PellegattiDimitri Colato
Jun 1, 2012·Expert Opinion on Drug Discovery·Dino MontanariTino Rossi
Jun 16, 2012·Drug Metabolism Reviews·Peter BallardPeter J H Webborn
May 6, 2011·Journal of Pharmaceutical Sciences·Joost WesterhoutElizabeth C M De Lange
Jun 10, 2011·Current Opinion in Pharmacology·Tino Rossi, Simone Braggio
May 7, 2011·Neurobiology of Learning and Memory·Stephen J Haggarty, Li-Huei Tsai
Mar 8, 2014·Journal of Medicinal Chemistry·André MateusPer Artursson
Jan 26, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Roger N GunnMarc Laruelle
Oct 6, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Susan ColeWilliam Speed
Oct 25, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Christoffer BundgaardTine B Stensbøl
Jul 17, 2014·Drug Discovery Today. Technologies·Sharan Bagal, Peter Bungay
Jul 8, 2011·The International Journal of Neuropsychopharmacology·Lucia CarboniPaolo Cavanni
Jun 2, 2012·Journal of Medicinal Chemistry·Francois BischoffHarrie J M Gijsen
Dec 19, 2017·European Journal of Drug Metabolism and Pharmacokinetics·Prashant B NigadeKumar V S Nemmani
Feb 14, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Keith RiccardiLi Di
Nov 13, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Raffaele LonghiHinnerk Boriss
Apr 9, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Li DiTheodore E Liston
Feb 22, 2018·Clinical Pharmacokinetics·Nithya SrinivasAngela D M Kashuba
Apr 21, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ana UgarteJulen Oyarzabal
Oct 28, 2020·Pharmaceutics·Lassina BadoloChristoffer Bundgaard
Dec 10, 2019·ACS Chemical Neuroscience·Mayuri GuptaDonald F Weaver

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.